What they were paid
Lyell Immunopharma Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $56,307 | $0 | $37,609 | $0 | $93,916 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lyell Immunopharma, Inc. DEF 14A filed April 24, 2026, accession 0001140361-26-016686, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Lyell Immunopharma pays directors a $50,000 cash retainer and $300,000 in Options.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Lyell Immunopharma board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Catherine Friedman | Lead Independent Director | $142,609 |
| Elizabeth Nabel | Independent Director | $102,609 |
| Lynn Seely | Director | $0 |
| Mark Bachleda | Independent Director | — |
| Otis Brawley | Independent Director | $97,609 |
| Richard Klausner | Chair of the Board | $122,609 |
| William Rieflin | Independent Director | $115,109 |
The full Lyell Immunopharma compensation record
free company briefThis page is one director within Lyell Immunopharma's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat